HMBA-induced differentiation of myeloid leukemic cell lines is associated with altered G1 cell cycle regulators and related genes.
Wang
Qin-hong
QH
Department of Hematology, Huashan Hospital, Medical Center of Fudan University, Shanghai 200040, China. qinhong_wang@yahoo.com.cn
Xie
Yi
Y
Fan
Hua-hua
HH
D000081:Acetamides / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D039481:CD11b Antigen / Q000032:analysis; D002454:Cell Differentiation / Q000187:drug effects*; D056741:Cyclin D; D019927:Cyclin E / Q000032:analysis; D016213:Cyclins / Q000032:analysis; D016193:G1 Phase; D016161:Genes, Retinoblastoma; D019254:Genes, bcl-2; D016259:Genes, myc; D018922:HL-60 Cells; D006801:Humans; D007951:Leukemia, Myeloid / Q000473:pathology*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D012313:RNA / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020298:U937 Cells
D000081:Acetamides; D000970:Antineoplastic Agents; D039481:CD11b Antigen; D056741:Cyclin D; D019927:Cyclin E; D016213:Cyclins; D018809:Proliferating Cell Nuclear Antigen; C413374:p27 antigen; D012313:RNA; C014026:hexamethylene bisacetamide